Phreesia Stock Intrinsic Value – Phreesia’s Q1 Results Outperform Expectations with GAAP EPS of -$0.58 and Revenue of $91.62M
December 11, 2023
🌥️Trending News
In addition, Phreesia ($NYSE:PHR) reported revenue of $91.62M, surpassing analyst projections by $1.82M. The company’s products range from online check-in to patient payments and can be tailored to the specific needs of each provider. Phreesia’s technology offers an easy way for patients to participate in their healthcare and create a better overall experience.
These impressive results show that Phreesia is well-positioned to continue growing and delivering value for its customers. With its suite of healthcare technology solutions, Phreesia is poised to become a leader in the healthcare industry and capitalize on the many opportunities ahead.
Earnings
In comparison to the previous year, this represents a 24.8% decrease in total revenue. Despite this slight dip, it is important to note that Phreesia has seen a substantial growth in total revenue in the last three years, reaching from 51.01M USD to 85.83M USD. In terms of net income, Phreesia lost 24.39M USD in the same quarter.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Phreesia. More…
| Total Revenues | Net Income | Net Margin |
| 337.88 | -144.26 | -42.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Phreesia. More…
| Operations | Investing | Financing |
| -45.2 | -38.11 | -22.91 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Phreesia. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 374.65 | 110.05 | 4.79 |
Key Ratios Snapshot
Some of the financial key ratios for Phreesia are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 34.2% | – | -42.9% |
| FCF Margin | ROE | ROA |
| -20.4% | -35.4% | -24.2% |
Stock Price
Despite the strong results, PHREESIA stock opened at $15.0 and closed at $14.8, a decrease of 2.8% from its last closing price of 15.2. This could be attributed to investors’ anticipation of upcoming earnings reports from other companies. Live Quote…
Analysis – Phreesia Stock Intrinsic Value
At GoodWhale, we have provided an analysis of PHREESIA‘s financials. After careful evaluation, we determined that the intrinsic value of PHREESIA share is around $52.9, as calculated by our proprietary Valuation Line. This assessment reveals that PHREESIA stock, which is currently traded at $14.8, is severely undervalued by 72.0%. This could be an ideal opportunity for investors looking for potential return on their investments. More…
Peers
Its competitors include Sharecare Inc, Aclarion Inc, and Cloud DX Inc.
– Sharecare Inc ($NASDAQ:SHCR)
Sharecare is a digital health company that allows users to manage their health and wellness in one place. The company has a wide range of products and services, including a social media platform, a health information database, and a mobile app. The company also offers a variety of health and wellness products and services, including fitness tracking, nutrition counseling, and stress management.
– Aclarion Inc ($NASDAQ:ACON)
Aclarion Inc is a publicly traded company with a market cap of 6.36M as of 2022. The company has a Return on Equity of -186.66%. Aclarion is a provider of cloud-based software solutions for the management of enterprise content. The company’s products and services include content management, document management, records management, and compliance management. Aclarion’s solutions are used by organizations in a variety of industries, including healthcare, financial services, government, and education.
– Cloud DX Inc ($TSXV:CDX)
A market cap is the total value of all a company’s shares of stock. Market cap is calculated by multiplying a company’s shares outstanding by the current market price of one share. The return on equity is a financial ratio that measures the profitability of a company in relation to the equity. The company’s equity is the difference between its total assets and total liabilities. The company’s ROE is its net income divided by its equity.
The company’s market cap is 10.81M as of 2022. The company’s ROE is 111.76%. The company’s net income is its total assets minus its total liabilities. The company’s market cap is its shares outstanding multiplied by the current market price of one share.
Summary
Phreesia is a healthcare technology company that provides patient intake and practice management software. Investing analysis on the company is positive, as PHREESIA recently reported its most recent quarterly earnings which were better than expected. The company posted a GAAP EPS of -$0.58, beating analyst estimates by $0.10.
PHREESIA also reported revenue of $91.62M, which was a beat of $1.82M compared to expectations. Going forward, investors will be monitoring the company’s performance to see if it can continue to beat estimates and report strong revenue growth.
Related Posts
Recent Posts
